Medtech
Polarean Imaging plc, the medical-imaging technology company, with a proprietary drug-device combination product for the magnetic resonance imaging market, announces that further to the announcement of 15 February 2019, the Company has delivered and installed its latest research unit order for a 9820 Xenon Polariser system from the University of British Columbia https://www.ubc.ca/.
Leading bioengineering company CN Bio has launched a fee for service program providing Human Organ-on-Chip data to scientists studying non-alcoholic steatohepatitis therapeutics.
Polarean Imaging plc, the medical-imaging technology company, with a proprietary magnetic resonance imaging (MRI) drug-device combination, announces that the enrolment for its Phase III non-inferiority clinical trials (the “Clinical Trials”) is now complete for both the lung transplant pathway and the lung resection pathway.
Pharmaceutical, medtech and biotech companies expand their leadership teams with this week’s appointments.
Through the use of cutting-edge gene sequencing, a team of researchers from Abbott Laboratories discovered a new strain of HIV, the first time a new subtype of HIV-1 has been identified in nearly 20 years.
walk2Wellness interim study data demonstrate improvement in balance, walking speed and fall reduction
First hospital in US to acquire French medtech firm’s CT-Navigation™ system to increase accuracy in radiology procedures, while decreasing treatment times and radiation exposure of patients and healthcare professionals
Further German cooperation with the Paracelsus Clinic in Zwickau and first NanoTherm treatment center outside of Germany opened at the Independent Public Clinical Hospital No. 4 (SPKS4) in Lublin, Poland
Hebrew SeniorLife, a Harvard Medical School Affiliate, is Fourth Study Site
New solution supports injection of different viscosities and volumes without the need for system customization
PRESS RELEASES